Role and Effectiveness of Rapid Diagnostic Tests in Home-based Management of Malaria
Launched by DBL -INSTITUTE FOR HEALTH RESEARCH AND DEVELOPMENT · Jan 13, 2010
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged between 6 months and 5 years (\< 5 years)reported with fever by the mother/ caretaker of the child
- • Children with uncomplicated malaria/ fever episodes
- • Children whose mothers consent to participate
- Exclusion Criteria:
- • Children aged less 6 months or greater than 4 years (≥ 5 years)
- • Children requiring referral to a health facility (severe malaria, complicated fever episode, convulsions/fits, loss of consciousness, and other danger signs)
- • Children whose mothers refuse to consent
About Dbl Institute For Health Research And Development
dbl - Institute for Health Research and Development is a leading clinical trial sponsor dedicated to advancing medical science through innovative research and rigorous clinical studies. With a commitment to improving patient outcomes, the institute collaborates with healthcare professionals, academic institutions, and industry partners to conduct high-quality research across various therapeutic areas. Leveraging state-of-the-art methodologies and a patient-centric approach, dbl strives to translate scientific discoveries into effective treatments, contributing significantly to the evolving landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rukungiri, , Uganda
Patients applied
Trial Officials
Richard Ndyomugyenyi, MD
Principal Investigator
Ministry of Health, Uganda
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials